Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Tablets: SOP for Real-Time Tablet Thickness Control – V 2.0

Posted on By

Tablets: SOP for Real-Time Tablet Thickness Control – V 2.0

Standard Operating Procedure for Real-Time Tablet Thickness Control

Department Quality Control
SOP No. SOP/TAB/123/2025
Supersedes SOP/TAB/123/2022
Page No. Page 1 of 6
Issue Date 01/03/2026
Effective Date 06/03/2026
Review Date 01/03/2027

1. Purpose

To define the procedure for real-time monitoring and control of tablet thickness during the compression process, ensuring uniformity and adherence to product specifications.

2. Scope

This SOP applies to the real-time monitoring of tablet thickness during the compression process in tablet manufacturing. It ensures that tablets are consistently within the required thickness specifications.

3. Responsibilities

  • Quality Control (QC): Responsible for monitoring tablet thickness in real-time, recording measurements, and ensuring the tablets meet the required thickness specifications.
  • Compression Operator: Responsible for adjusting compression settings to maintain tablet thickness within specification limits during production.
  • Quality Assurance (QA): Reviews the thickness monitoring data and ensures compliance with the required specifications. Investigates deviations and documents corrective actions.

4. Accountability

The QC Manager is accountable for ensuring real-time monitoring and control of tablet thickness during the compression process. The QA Manager is responsible for reviewing records and ensuring compliance with internal and regulatory standards.

See also  Tablets: SOP for Tablet Compression Force Monitoring and Adjustments - V 2.0

5. Procedure

5.1 Sample Collection

  1. During tablet compression, collect a
representative sample of tablets at regular intervals, typically every 15 minutes or after producing a set number of tablets (e.g., every 100 tablets).
  • Ensure that the sample size is sufficient for accurate measurements, usually 10 tablets per sample.
  • 5.2 Tablet Thickness Measurement

    1. Use a calibrated tablet thickness gauge or micrometer to measure the thickness of each tablet in the sample.
    2. Ensure that the instrument is properly calibrated and zeroed before taking measurements.
    3. Record the thickness value of each tablet and calculate the average thickness of the sample.
    4. If applicable, measure the thickness at multiple points on each tablet to ensure uniformity.

    5.3 Real-Time Monitoring and Adjustment

    1. Monitor tablet thickness continuously during the compression process, making adjustments as needed to ensure tablets are within the specified thickness range.
    2. If the measured tablet thickness deviates from the target thickness (typically ±10% of the target thickness), adjust the compression machine settings accordingly, such as adjusting the compression force, tablet fill weight, or machine speed.
    3. After adjusting the compression machine, re-sample and measure the tablet thickness to verify that the adjustments resulted in tablets meeting the target thickness.

    5.4 Monitoring Frequency

    1. Tablet thickness should be monitored at regular intervals throughout the compression process, typically every 15 minutes or after every 100 tablets produced.
    2. If any irregularities are observed, increase the frequency of monitoring until the issue is resolved.

    5.5 Documentation

    1. Record the following information during each tablet thickness monitoring interval:
      • Sample number and time of collection
      • Individual tablet thickness values
      • Average tablet thickness
      • Deviation from target thickness and any adjustments made
    2. Document any deviations from the target thickness and corrective actions taken in the deviation report (Annexure-1).
    3. Ensure that all records are signed and dated by the responsible personnel and reviewed by QA for compliance.

    5.6 Acceptance Criteria

    1. The tablet thickness should be within the specified range, typically ±10% of the target thickness.
    2. If the tablet thickness falls outside the acceptable limits, investigate the cause and take corrective actions, including potential rework or rejection of the batch.

    5.7 Post-Compression Actions

    1. Once the tablet thickness is within specification, proceed with the other post-compression processes, such as coating, packaging, and storage.
    2. Ensure that any adjustments made to the compression machine are recorded and that the equipment is cleaned and calibrated as required.

    6. Abbreviations

    • SOP: Standard Operating Procedure
    • GMP: Good Manufacturing Practice
    • QC: Quality Control
    • QA: Quality Assurance
    • API: Active Pharmaceutical Ingredient

    7. Documents

    1. Batch Record (Annexure-2)
    2. Deviation Report (Annexure-1)

    8. References

    • USP <121> – Tablet Thickness Testing
    • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals (US FDA)
    • European Pharmacopoeia (EP) – Specifications for Tablet Thickness

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Deviation Report

    Deviation Date Batch Number Deviation Description Corrective Action Responsible Person
    15/12/2025 Batch 001 Tablet thickness deviation > 10% Adjusted compression force and re-tested John Doe

    Annexure-2: Batch Record

    Sample Number Tablet Thickness (mm) Average Thickness (mm) Deviation (%) Action Taken
    Sample 1 4.80 4.75 ±1.2% Accepted

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/01/2024 1.0 Initial Version New SOP Creation QA Head
    01/02/2025 2.0 Updated tablet thickness acceptance criteria Refined quality control processes QA Head
    Tablet Manufacturing V2.0 Tags:GMP tablet manufacturing SOP, SOP for tablet production, SOP for tablet quality control, SOP tablet inspection process, SOP tablet packing and sealing, Tablet batch record review, Tablet blending SOP, Tablet cleaning and maintenance, Tablet coating procedure, Tablet compression SOP, Tablet disintegration test procedure, Tablet dissolution procedure, Tablet formulation SOP, Tablet friability testing SOP, Tablet labeling and packaging SOP, Tablet manufacturing equipment SOP, Tablet manufacturing SOP, Tablet manufacturing SOPs, Tablet packaging SOP, Tablet production procedure, Tablet quality assurance SOP, Tablet quality control SOP, Tablet sampling and in-process testing SOP, Tablet stability testing SOP, Tablet storage and handling procedure, Tablet uniformity testing procedure, Tablet weight variation SOP

    Post navigation

    Previous Post: Job Safety Analysis for Tablet Inspection System
    Next Post: Creams: SOP for Weighing and Dispensing of Viscosity Modifiers for Creams – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version